Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.

Cortes, J E; Kantarjian, H; O'Brien, S; Keating, M; Pierce, S; Freireich, E J; Estey, E

Cortes, J E; Kantarjian, H; O'Brien, S; Keating, M; Pierce, S; Freireich, E J; Estey, E.

Affiliation

Cortes JE; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

Leukemia ; 9(1): 115-7, 1995 Jan.

Article in En | MEDLINE | ID: mdl-7845005

Subject(s)

Down Syndrome/genetics; Leukemia, Myeloid, Acute/genetics; Myelodysplastic Syndromes/genetics; Adolescent; Adult; Aged; Chromosome Aberrations; Female; Humans; Leukemia, Myeloid, Acute/drug therapy; Male; Middle Aged; Myelodysplastic Syndromes/drug therapy; Prognosis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Down Syndrome Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1995 Type: Article

Search on Google

XML

PubMed Links